COVID-19 issues related to COVID-19 health care legislative and regulatory implementation and funding issues; COVID-19 relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); implementation of Provider Relief Funding and other COVID-19 relief, including Medicare/Medicaid waivers; and the HEROES Act (H.R. 6800); Delivering Immediate Relief to America's Families, Schools and Small Businesses Act (S. 4775), and Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Continuing Appropriations Act, 2021 and Other Extensions Act (H.R.8337); Consolidated Appropriations Act, 2021 (H.R. 133); telehealth, rural health; The Resetting The Impact Act (TRIA)(H.R. 8826) and Critical Access Hospitals.
COVID-19 issues related to COVID-19 health care legislative and regulatory implementation and funding issues; COVID-19 relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); implementation of Provider Relief Funding and other COVID-19 relief, including Medicare/Medicaid waivers; and the HEROES Act (H.R. 6800); Delivering Immediate Relief to America's Families, Schools and Small Businesses Act (S. 4775), and Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Continuing Appropriations Act, 2021 and Other Extensions Act (H.R.8337); Consolidated Appropriations Act, 2021 (H.R. 133); telehealth, rural health, ; The Resetting The Impact Act (TRIA)(H.R. 8826); and Critical Access Hospitals.
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2020: House of Representatives, U.S. Senate, Health & Human Services - Dept of (HHS)
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Snr Cnsl, Joint Econ Committee, Mar 17-Nov 17; Leg cnsl, Sen Heinrich, Apr 14-Mar 17; Leg Asst, Rep Doris Matsui, Dec 11-Apr 14; Leg Asst, Senate Judiciary Committee, May 09-Aug 09; Research Analyst, Senate Small Business Committee, Jun 07-Aug 08
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Q2 Report
Registration
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...